| Year |
Citation |
Score |
| 2019 |
Rescourio G, Gonzalez AZ, Jabri S, Belmontes B, Moody G, Whittington D, Huang X, Caenepeel S, Cardozo M, Cheng AC, Chow D, Dou H, Jones A, Kelly RC, Li Y, ... ... Zancanella M, et al. Discovery and in Vivo Evaluation of Macrocyclic Mcl-1 Inhibitors Featuring an α-Hydroxy Phenylacetic Acid Pharmacophore or Bioisostere. Journal of Medicinal Chemistry. PMID 31736296 DOI: 10.2210/Pdb6Udi/Pdb |
0.387 |
|
| 2011 |
Al-Mourabit A, Zancanella MA, Tilvi S, Romo D. Biosynthesis, asymmetric synthesis, and pharmacology, including cellular targets, of the pyrrole-2-aminoimidazole marine alkaloids. Natural Product Reports. 28: 1229-60. PMID 21556392 DOI: 10.1039/C0Np00013B |
0.427 |
|
| 2008 |
Richardson RD, Ma G, Oyola Y, Zancanella M, Knowles LM, Cieplak P, Romo D, Smith JW. Synthesis of novel beta-lactone inhibitors of fatty acid synthase. Journal of Medicinal Chemistry. 51: 5285-96. PMID 18710210 DOI: 10.1021/Jm800321H |
0.479 |
|
| 2008 |
Zancanella MA, Romo D. Facile synthesis of the trans-fused azabicyclo[3.3.0]octane core of the palau'amines and the tricyclic core of the axinellamines from a common intermediate. Organic Letters. 10: 3685-8. PMID 18693745 DOI: 10.1021/Ol801289B |
0.445 |
|
| 2006 |
Ma G, Zancanella M, Oyola Y, Richardson RD, Smith JW, Romo D. Total synthesis and comparative analysis of orlistat, valilactone, and a transposed orlistat derivative: Inhibitors of fatty acid synthase. Organic Letters. 8: 4497-500. PMID 16986934 DOI: 10.1021/Ol061651O |
0.486 |
|
| Show low-probability matches. |